OS Therapies IncorporatedOSTXNYSE
Loading
EV/EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-12.27
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-196976.39
Historical baseline
PeriodValueYoY Change
2024-12.27+18.0%
2023-14.96+2.4%
2022-15.33-14.1%
2021-13.43+100.0%
2020-984825.96-